Ⓐ
PeptiBrief
Peptide · Research peptide

Sermorelin

Research peptide
Aliases · GHRH analogue · GHRH(1-29)NH2 · GRF 1-29 · GHRH(1-29)

Sermorelin is an investigational peptide, analogue or research construct with evidence ranging from mechanistic studies to limited human trials.

Human
1/5
Animal
0/5
In-vitro
0/5
Safety
0/5
Last reviewed · 7/12/2026
Compare with another peptide →
Last reviewed7/12/2026
Evidence statusEarly entry
Published references0
Trust signal panel
Evidence & safety
  • Human evidence
    n/a
  • Animal evidence
    n/a
  • Mechanistic
    n/a
  • Safety knowledge
    n/a
  • Editorial confidence
    3/5
View in knowledge graph →See this peptide connected to conditions & mechanisms
01

Evidence Snapshot

Evidence snapshot · 1 verified ref
Overall
1/5Insufficient certainty
Human
1/5Only review or summary sources indexed (not counted as primary human evidence)
Animal
0/5None identified
In-vitro
0/5None identified
Safety
0/5None identified
02

Scientific identity

Peptide family
Investigational peptide or analogue
Entity class
Research peptide
Alternative names
GHRH analogueGHRH(1-29)NH2GRF 1-29GHRH(1-29)
Discovery history

Sermorelin entered research, clinical or commercial use through investigation of its proposed biological, cosmetic or therapeutic activity.

02

Proposed Mechanisms

03

Reported / Studied Uses

04

Human Evidence

Human evidence is absent, limited, early phase or indication-specific.

05

Animal Evidence

Animal evidence may support biological activity but does not establish clinical efficacy.

Species translation to humans is uncertain.
06

Safety & Unknowns

prescription-historyoff-label-claimsigf-1-elevationcompounded-product-risklong-term-safety-uncertaininvestigationallimited-human-evidenceno-established-general-use
Long-term safety, validated dosing and product quality may be uncertain outside formal clinical development.
07

Regulatory Status

CountryStatusNotes
08

Community Observations

No approved community reports yet. Submit one. Aggregate data is observational only.
09

References

  • No verified references linked yet. Editors will add primary sources.
10

Full Disclaimer

This page is for educational information only. It does not constitute medical advice, diagnosis, treatment, dosing guidance, or a recommendation to use any peptide, medicine or research chemical. Many peptides discussed on Atlas are not approved for human use in most jurisdictions and may have limited or unknown long-term safety data.

Community observations shown on this page are anonymised, moderated and observational only. They do not establish safety or effectiveness.

Always consult a qualified healthcare professional before making decisions about your health. See medical disclaimer and methodology.

↳

Explore further

from the knowledge graph
Advertise here — support independent evidence →
ImportantPeptiBrief is an educational information platform. It does not diagnose, prescribe, sell peptides, recommend dosing, encourage self-experimentation or replace qualified medical care. Published scientific evidence is kept separate from community observations and uncertainty.